A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

The actor said he lost 40 pounds taking GLP-1 medication before a negative side effect necessitated a change to a different ...

Wells Fargo lowered the firm’s price target on Eli Lilly (LLY) to $970 from $1,000 and keeps an Overweight rating on the shares. The firm ...

Novo Nordisk and Eli Lilly's motion to dismiss took aim at most of the counts asserted in the plaintiffs’ master long-form ...

Wezempic Logo. New online community launches to support those using Ozempic, Wegovy, and Mounjaro. LONDON, LONDON, UNITED KINGDOM, January 27, 2025 /EINPre ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

We recently published a list of 12 Stocks That Could Split in the Near Future. In this article, we are going to take a look ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

An array of pharmaceutical pills with the company's logo on the bottle ... “See, I'm thinking that Lilly’s wonder drug ...

We recently compiled a list of the 10 Best Stocks to Invest in According to Billionaire Cliff Asness. In this article, we are ...

Mounjaro (tirzepatide) is a brand-name drug prescribed to treat type 2 diabetes in adults. Mounjaro comes as a solution inside injection pens that you’ll administer weekly as a subcutaneous ...